Fortress Biotech, Inc. (FBIO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 203.85M | -12.54M | -6.11M | -27.56M | -19.56M | -12.91M | -20.06M | -21.84M | -25.39M | -34.94M | -16.78M | -33.29M |
| Operating CF Margin % | 1271.05% | -78.01% | -34.65% | -167.92% | -148.89% | -85.36% | -137.12% | -146.6% | -194.84% | -175.15% | -48.28% | -191.48% |
| Operating CF Growth % | 1142.02% | 2.81% | 69.54% | -26.2% | 22.94% | 63.05% | -19.55% | 34.4% | 41.26% | 26.98% | 61.23% | 19.63% |
| Net Income | 110.37M | -5.4M | 8.83M | -11.65M | -24.69M | -26.32M | -26.69M | -10.95M | -39.02M | -9.28M | -10.72M | -24.78M |
| Depreciation & Amortization | 1.7M | 1.16M | 1.16M | 1.16M | 1.68M | -1.24M | 3.32M | 1.19M | 1.19M | 1.71M | 2.75M | 2.43M |
| Stock-Based Compensation | 0 | 2.46M | 3.2M | 16.79M | 6.29M | 16.19M | 6.57M | 5M | 4.86M | 3.7M | 4.38M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.85M | -5M | 0 |
| Other Non-Cash Items | 35.99M | 42K | -14.76M | -27.08M | 143K | 4.19M | 2.31M | -13.89M | 1.92M | 7.93M | 76K | -18.69M |
| Working Capital Changes | 55.79M | -10.8M | -4.53M | -6.78M | -2.98M | -5.73M | -5.58M | -3.19M | 5.67M | -18.15M | -8.26M | 7.75M |
| Change in Receivables | 4.4M | -11.78M | -2M | 2.57M | -8.13M | 750K | -827K | -712K | 5.26M | -7.18M | 8.83M | 10.79M |
| Change in Inventory | 332K | 2.19M | 1.03M | -356K | 1.94M | -2.64M | -2.1M | 893K | -374K | 818K | 1.14M | 1.11M |
| Change in Payables | 45.94M | 2.68M | -2.83M | -8.37M | 550K | 728K | -4.99M | -5.5M | 2.67M | -7.36M | -17.45M | -4.34M |
| Cash from Investing | 0 | 0 | 2.87M | 6.09M | 1.17M | -15M | 0 | 0 | 0 | -63K | 5M | -2.04M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28K | -1K | -7.03M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 0.14% | 0% | 40.46% |
| Acquisitions | 0 | 0 | 2.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 6.09M | 1.17M | -15M | 0 | 0 | 0 | -35K | 5M | -5K |
| Cash from Financing | -27.39M | 5.71M | 15.07M | 4.52M | 52.14M | 25.81M | 2.71M | 14.27M | 27.86M | 43.62M | -2.69M | -30.38M |
| Debt Issued (Net) | -14.49M | 0 | -704K | -4.93M | -625K | 5M | -17.33M | 5M | 0 | 14.62M | -10M | -44.12M |
| Equity Issued (Net) | -12.9M | 5.87M | 14.14M | 9M | 52.82M | 21.19M | 20.72M | 15.99M | 29.88M | 30.71M | 10.4M | 15.93M |
| Dividends Paid | 0 | -166K | -166K | -166K | -166K | -166K | -176K | -2.18M | -2.18M | -2.19M | -2.19M | -2.19M |
| Share Repurchases | -14.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 1.8M | 619K | 116K | -217K | -501K | -4.55M | 163K | 479K | -889K | 0 |
| Net Change in Cash | 176.46M | -6.84M | 11.83M | -16.95M | 33.74M | -2.1M | -17.35M | -7.57M | 2.47M | 6.18M | -14.46M | -65.71M |
| Free Cash Flow | 203.85M | -12.54M | -6.11M | -27.56M | -19.56M | -12.91M | -20.06M | -21.84M | -25.39M | -35M | -17.78M | -33.33M |
| FCF Margin % | 1271.05% | -78.01% | -34.65% | -167.92% | -148.89% | -85.36% | -137.12% | -146.6% | -194.84% | -175.46% | -51.16% | -191.68% |
| FCF Growth % | 1142.02% | 2.81% | 69.54% | -26.2% | 22.94% | 63.12% | -12.82% | 34.47% | 41.26% | 48.74% | 59.86% | 46.02% |
| FCF per Share | 5.31 | -0.04 | -0.18 | -0.92 | -0.74 | -0.64 | -1.02 | -1.19 | -1.48 | -4.48 | -2.37 | -4.52 |
| FCF Conversion (FCF/Net Income) | 1.85x | 3.19x | -1.04x | -1.78x | 1.85x | 1.91x | 1.56x | 1.99x | 1.65x | 3.76x | 3.33x | 1.34x |
| Interest Paid | 0 | 1.71M | 1.75M | 604K | 0 | 1.76M | 1.86M | 0 | 1.66M | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 5K | 0 | 0 | 0 | 0 | 0 | 0 |